| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.046 | 0.8 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |